Diphosphonates Concept

subject area of

• 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis  Journal Articles
• A 99mTc-Labelled Tetrazine for Bioorthogonal Chemistry. Synthesis and Biodistribution Studies with Small Molecule trans-Cyclooctene Derivatives  Journal Articles
• A community-based clinical trial of Intra-Venous zOledRonic acid once Yearly in comparison to oral bisphosphonates in postmenopausal women with osteoporosis: The IVORY trial  Journal Articles
• A metaanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis.  Journal Articles
• A phase I dose-ranging trial of monthly infusions of zoledronic acid for the treatment of osteolytic bone metastases.  Journal Articles
• A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events  Journal Articles
• A randomised trial comparing 6-monthly adjuvant zoledronate with a single one-time dose in patients with early breast cancer  Journal Articles
• A reappraisal of generic bisphosphonates in osteoporosis  Journal Articles
• Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database  Journal Articles
• Adherence to osteoporosis pharmacotherapy is underestimated using days supply values in electronic pharmacy claims data  Journal Articles
• Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey  Journal Articles
• Advances in osteoporosis therapy. 2003 update of practical guidelines.  Journal Articles
• Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP)  Journal Articles
• Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture  Journal Articles
• Are bisphosphonates useful in the management of corticosteroid induced osteoporosis in transplant patients?  Journal Articles
• Association between timing of zoledronic acid infusion and hip fracture healing  Journal Articles
• Asymptomatic Primary Hyperparathyroidism—Commentary on Current Management  Journal Articles
• Atypical Femoral Fractures: A Teaching Perspective  Journal Articles
• Atypical femoral fracture  Journal Articles
• Bisphosphonate Associated Osteonecrosis of the Jaw  Journal Articles
• Bisphosphonate Therapy for Reduced Bone Mineral Density During Treatment of Acute Lymphoblastic Leukemia in Childhood and Adolescence  Journal Articles
• Bisphosphonate addition to stable hormone replacement therapy increases bone mineral density in postmenopausal women.  Journal Articles
• Bisphosphonate drug holidays: we reap what we sow  Journal Articles
• Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada  Journal Articles
• Bisphosphonate-Induced Orbital Inflammation: A Case Series and Review  Journal Articles
• Bisphosphonate-associated Osteonecrosis of the Jaw in Ontario: A Survey of Oral and Maxillofacial Surgeons  Journal Articles
• Bisphosphonates Target B Cells to Enhance Humoral Immune Responses  Journal Articles
• Bisphosphonates and skeletal morbidity in patients with metastatic cancer.  Journal Articles
• Bisphosphonates for osteoporosis in people with cystic fibrosis  Journal Articles
• Bisphosphonates for steroid induced osteoporosis  Journal Articles
• Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.  Journal Articles
• Bone Affinity of a Bisphosphonate-Conjugated Protein in Vivo  Journal Articles
• Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme in Evidence-based Care — Cancer Care Ontario Clinical Practice Guideline  Journal Articles
• Bone Mineral Metabolism In Pediatric Inflammatory Bowel Disease  Journal Articles
• Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid Tumors  Journal Articles
• Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.  Journal Articles
• Cancer Treatment–Induced Bone Loss in Breast and Prostate Cancer  Journal Articles
• Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ  Journal Articles
• Changes in cross‐sectional geometry of the distal femoral metaphysis associated with inflammatory arthritis are reduced by a bisphosphonate (zoledronate)  Journal Articles
• Clinical Risk Factors for Recurrent Fracture after Hip Fracture: A Prospective Study  Journal Articles
• Clinical Utility of Biochemical Markers of Bone Metabolism for Improving the Management of Patients with Advanced Multiple Myeloma  Journal Articles
• Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis  Journal Articles
• Comment on Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis  Journal Articles
• Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients  Journal Articles
• Corticosteroid-Induced Osteoporosis  Journal Articles
• Corticosteroid-Induced Osteoporosis  Journal Articles
• Corticosteroid-Induced Osteoporosis  Journal Articles
• Current treatment options for osteoporosis.  Journal Articles
• Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis  Journal Articles
• Denosumab: mechanism of action and clinical outcomes  Journal Articles
• Diagnosis and Management of Atypical Femoral Fractures and Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis.  Journal Articles
• Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus  Journal Articles
• Diagnosis and treatment of Paget’s disease of bone  Journal Articles
• Discordance between Receptor Status in Primary and Metastatic Breast Cancer: an Exploratory Study of Bone and Bone Marrow Biopsies  Journal Articles
• Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12  Journal Articles
• Drug-Related Adverse Events of Osteoporosis Therapy  Journal Articles
• Effect of Bisphosphonates on Periprosthetic Bone Mineral Density After Total Joint Arthroplasty  Journal Articles
• Effect of Bisphosphonates on Periprosthetic Bone Mineral Density After Total Joint Arthroplasty  Journal Articles
• Effect of bisphosphonates on pain and quality of life in patients with bone metastases  Journal Articles
• Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer  Journal Articles
• Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk Among Oral Glucocorticoid Users: Three Matched Cohort Analyses  Journal Articles
• Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study  Journal Articles
• Efficacy of Bisphosphonates in the Management of Skeletal Complications of Bone Metastases and Selection of Clinical Endpoints  Journal Articles
• Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints.  Journal Articles
• Fracture risk and treatment in chronic kidney disease  Journal Articles
• Fractures are increased and bisphosphonate use decreased in individuals with insulin-dependent diabetes: a 10 year cohort study  Journal Articles
• Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study  Journal Articles
• Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS study  Journal Articles
• Glucocorticoid induced osteoporosis  Journal Articles
• Glucocorticoid-induced osteoporosis  Journal Articles
• Health-Related Quality of Life and Participation in Osteoporosis Clinical Trials  Journal Articles
• Histomorphometry and Bone Matrix Mineralization Before and After Bisphosphonate Treatment in Boys With Duchenne Muscular Dystrophy: A Paired Transiliac Biopsy Study  Journal Articles
• Hypocalcemia Risk of Denosumab Across the Spectrum of Kidney Disease: A Population-Based Cohort Study  Journal Articles
• Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data  Journal Articles
• Improved radiosynthesis and preliminary in vivo evaluation of the 11C-labeled tetrazine [11C]AE-1 for pretargeted PET imaging  Journal Articles
• Improving care after hip fracture: the fracture? Think osteoporosis (FTOP) program  Journal Articles
• In whom and how to prevent glucocorticoid-induced osteoporosis  Journal Articles
• Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: A national observational study  Journal Articles
• Increased growth rate and tumor burden of spontaneously metastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated rats.  Journal Articles
• Inhibition of adenosine kinase by phosphonate and bisphosphonate derivatives  Journal Articles
• Insufficient evidence to support the use of locally delivered bisphosphonates to improve dental implant outcomes  Journal Articles
• Legacy Drug-Prescribing Patterns in Primary Care  Journal Articles
• Long-Term Tolerability of the Bisphosphonates in Postmenopausal Osteoporosis  Journal Articles
• Long-term impact of adherence to oral bisphosphonates on osteoporotic fracture incidence  Journal Articles
• Management of Glucocorticoid-Induced Osteoporosis  Journal Articles
• Management of Low Bone Mineral Density in Premenopausal Women  Journal Articles
• Management of corticosteroid-induced osteoporosis  Journal Articles
• Markers of Bone Metabolism and Survival in Men with Hormone-Refractory Metastatic Prostate Cancer  Journal Articles
• Medical Management of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop  Conferences
• Medical Management of Primary Hyperparathyroidism  Journal Articles
• Micrometer-Sized Magnesium Whitlockite Crystals in Micropetrosis of Bisphosphonate-Exposed Human Alveolar Bone  Journal Articles
• Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study  Journal Articles
• Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity  Journal Articles
• Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid  Journal Articles
• Once-Yearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture  Journal Articles
• Optimal management of metastatic bone disease  Journal Articles
• Optimal management of metastatic bone disease  Journal Articles
• Oral bisphosphonate use in the elderly is not associated with acute kidney injury  Journal Articles
• Oral bisphosphonates  Journal Articles
• Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS  Journal Articles
• Osteonecrosis of the jaw and bisphosphonates  Journal Articles
• Osteonecrosis of the jaw: new developments in an old disease.  Journal Articles
• Osteopenia in children with acute lymphoblastic leukemia: A pilot study of amelioration with pamidronate  Journal Articles
• Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatment  Journal Articles
• Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage  Journal Articles
• Osteoporosis prescribing trends in primary care: a population-based retrospective cohort study  Journal Articles
• Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor–positive breast cancer: NCIC CTG MA.27  Journal Articles
• Osteoporosis treatment rate following hip fracture in a community hospital  Conferences
• Osteoporosis treatment rate following hip fracture in a community hospital  Journal Articles
• Ostéoporose pendant la ménopause  Journal Articles
• Parathyroid hormone for the treatment of osteoporosis: a systematic review  Journal Articles
• Patient Adherence to Osteoporosis Medications  Journal Articles
• Patient Management, and Time and Health Care Resource Utilization Associated with the Use of Intravenous Bisphosphonates For Patients with Metastatic Bone Disease: A Delphi Study  Journal Articles
• Patient and Physician Decisional Factors Regarding Hypercalcemia of Malignancy Treatment: A Novel Mixed-Methods Study  Journal Articles
• Persistence with denosumab therapy among osteoporotic women in the Canadian patient-support program  Journal Articles
• Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians  Journal Articles
• Pharmacological Treatment of Ankylosing Spondylitis  Journal Articles
• Postmenopausal Osteoporosis  Journal Articles
• Predictive Value of Bone Resorption and Formation Markers in Cancer Patients With Bone Metastases Receiving the Bisphosphonate Zoledronic Acid  Conferences
• Predictors of Skeletal Complications in Men with Hormone-Refractory Metastatic Prostate Cancer  Journal Articles
• Premenopausal women and low bone density.  Journal Articles
• Preparation and Evaluation of ^99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry  Journal Articles
• Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis.  Journal Articles
• Primary hyperparathyroidism: Update on presentation, diagnosis, and management in primary care.  Journal Articles
• Rational use of oral bisphosphonates for the treatment of osteoporosis  Journal Articles
• Relevant clinical end points in biphosphonate trials.  Journal Articles
• Reply to T.J. Powles et al  Journal Articles
• Reply: Can Bisphosphonates Prevent Vitamin K Antagonist Toxicity in Patients with Idiopathic Pulmonary Fibrosis?  Journal Articles
• Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW)  Journal Articles
• Risk reduction of non-vertebral fractures with intravenous ibandronate: post-hoc analysis from DIVA  Journal Articles
• Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update  Journal Articles
• Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis  Journal Articles
• Screening for Osteoporosis in Postmenopausal Women With Breast Cancer Receiving Aromatase Inhibitors: Less Is More?  Journal Articles
• Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture  Journal Articles
• Subtrochanteric Fractures in Bisphosphonate-Naive Patients: Results from the HORIZON-Recurrent Fracture Trial  Journal Articles
• Tetrazine-Derived Near-Infrared Dye for Targeted Photoacoustic Imaging of Bone  Journal Articles
• The (mis) use of bone resorption markers in the context of bisphosphonate exposure, dental surgery and osteonecrosis of the jaw  Journal Articles
• The Canadian Home Total Parenteral Nutrition (HTPN) Registry  Journal Articles
• The HORIZON Recurrent Fracture Trial: design of a clinical trial in the prevention of subsequent fractures after low trauma hip fracture repair  Journal Articles
• The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function  Conferences
• The Role of Bisphosphonates in Malignant Bone Pain: A Review  Journal Articles
• The Use of Zoledronic Acid, a Novel, Highly Potent Bisphosphonate, for the Treatment of Hypercalcemia of Malignancy  Journal Articles
• The association between compliance and persistence with bisphosphonate therapy and fracture risk: A review  Journal Articles
• The gastrointestinal tolerability and safety of oral bisphosphonates  Journal Articles
• The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study  Journal Articles
• The osteoporosis care gap in Canada  Journal Articles
• The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study  Journal Articles
• The treatment of glucocorticoid-induced osteoporosis  Journal Articles
• The use of bisphosphonates in men with hormone-refractory prostate cancer: a systematic review of randomized trials.  Journal Articles
• Time and Labor Costs Associated With Administration of Intravenous Bisphosphonates for Breast or Prostate Cancer Patients With Metastatic Bone Disease: A Time and Motion Study  Journal Articles
• Tolerability of Different Dosing Regimens of Bisphosphonates for the Treatment of Osteoporosis and Malignant Bone Disease  Journal Articles
• Treating osteoporosis: economic aspects of bisphosphonate therapy  Journal Articles
• Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline  Journal Articles
• Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians  Journal Articles
• Tumor-bone interactions in skeletal metastasis.  Journal Articles
• Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline  Journal Articles
• Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update  Journal Articles
• Use of Osteobiologics in the Management of Osteoporotic Fractures  Journal Articles
• What are the beliefs, attitudes and practices of front-line staff in long-term care (LTC) facilities related to osteoporosis awareness, management and fracture prevention?  Journal Articles
• Which Bone-Modifying Agent is Associated with Better Outcomes in Patients with Skeletal Metastases from Lung Cancer? A Systematic Review and Network Meta-analysis  Journal Articles
• Zoledronate (CGP 42'446), a bisphosphonate, protects against metaphyseal intracortical defects in experimental inflammatory arthritis  Journal Articles
• Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials  Journal Articles
• Zoledronic Acid and Survival in Breast Cancer Patients with Bone Metastases and Elevated Markers of Osteoclast Activity  Journal Articles
• Zoledronic Acid and Survival in Patients with Metastatic Bone Disease from Lung Cancer and Elevated Markers of Osteoclast Activity  Journal Articles
• Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity.  Journal Articles
• Zoledronic acid in the treatment of hypercalcemia of malignancy: Results of the international clinical development program  Journal Articles
• Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion  Journal Articles
• Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON–Recurrent Fracture Trial  Journal Articles
• Zoledronic acid use in cancer patients  Journal Articles
• [Are there differences in bisphosphonates? (interview by Dr. Beate Schumacher)].  Journal Articles